Should You Invest in Exact Sciences Corporation (EXAS) Now?
Baron Funds, an investment management company, released its “Baron Health Care Fund” first quarter 2023 investor letter. A copy of the same can be downloaded here.
Posts Tagged ‘NASDAQ:EXAS’
Exact Sciences Corporation (NASDAQ:EXAS) Q1 2023 Earnings Call Transcript
Operator: Thank you for standing by. My name is Jordan, and I'll be your conference operator today.
5 Gene Editing Stocks With the Best Long-Term Potential
In this article, we will take a look at the 5 gene editing stocks with the best long-term potential.
Cathie Wood’s Stock Portfolio: Top 5 Stock Picks For 2023
In this article, we will look at Cathie Wood's top 5 stock picks for 2023.
5 Most Promising Gene Editing Stocks According to Analysts
In this article, we will take a look at the 5 most promising gene editing stocks according to analysts.
Exact Sciences Corporation (NASDAQ:EXAS) Q4 2022 Earnings Call Transcript
Operator: Good morning. My name is Rob and I will be your conference operator today.
Ark Invest Stock Portfolio: 5 Biggest Positions
In this article, we discuss the 5 biggest positions in the ARK Invest portfolio.
5 Best ARK Stocks To Buy Now
In this article, we discuss the 5 best ARK stocks to buy now.
9 Cheap Stocks to Buy According to Cathie Wood
In this article, we discuss the 9 cheap stocks to buy according to Cathie Wood.
15 Stocks That Will Double In 2023
In this article, we will discuss 15 stocks that will double in 2023.
5 Biggest Genomics Companies In The World
In this article, we will discuss the 5 Biggest Genomics Companies In The World.
ARK Invest Stock Portfolio: Top 5 Picks
In this article, we discuss the top 5 stock picks from the ARK Invest stock portfolio.
“The Fed Has Overreacted”: 10 Risky Stocks to Buy Today
In this article, we will be taking a look at the 10 risky stocks to buy today in line with the expectation of a soft landing.
Cathie Wood is Buying These 10 Stocks in September
In this article, we discuss 10 stocks that Cathie Wood is buying in September.
Top 5 From Cathie Wood’s Q2 Portfolio
In this article, we will be taking a look at the top 5 from Cathie Wood's Q2 portfolio.
5 Cathie Wood Stocks that Can Rebound in Q4
In this article, we discuss 5 Cathie Wood stocks that can rebound in Q4.
Top 10 Stock Picks of Eli Casdin’s Casdin Capital
In this article, we discuss the top 10 stock picks of Eli Casdin's Casdin Capital.
Cathie Wood’s Top 10 Buys in July
In the beginning of July, Cathie Wood of ARK Investment Management admitted that while her predictions about inflation were wrong, the US seems to be heading towards a deflationary...
Cathie Wood is Not Letting Go of These 10 Stocks Despite Losses
In this article, we discuss 10 stocks that Cathie Wood is not letting go of despite losses.
Cathie Wood’s Fund Starts to Rebound: 5 Stocks to Watch
In this article, we discuss 5 stocks to watch as Cathie Wood's fund starts to rebound.
Cathie Wood and Steve Cohen Love These 10 Stocks
In this article, we discuss 10 stocks that Cathie Wood and Steve Cohen love.
12 Best ARK Stocks To Buy Now
In this article, we discuss the 12 best ARK stocks to buy now.
10 Stocks in Focus After Posting Their Earnings Reports
In this article, we will take a look at the 10 stocks in focus after posting their earnings reports.
Here’s Why You Should Remain Optimistic in Exact Sciences Corp. (EXAS)
RiverPark Funds, an investment management firm, published its “RiverPark Large Growth Fund” third quarter 2021 investor letter – a copy of which can be downloaded here.
Were Expert Investors Right About EXACT Sciences Corporation (EXAS)?
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy...
5 Best Genomics Stocks to Buy Now
In this article, we will discuss the 5 best genomics stocks to buy now.
EXACT Sciences Corporation (EXAS): Are Hedge Funds Right About This Stock?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Cathie Wood’s ARK Portfolio: Top 15 Losers
In this article, we discuss the 15 biggest losers in the portfolio of Cathie Wood's ARK.
Here’s Why Exact Sciences (EXAS) Landed in RiverPark’s Detractor List
RiverPark Funds, an investment management firm, published its “RiverPark Large Growth Fund” third quarter 2021 investor letter – a copy of which can be downloaded here.
Here’s Why Artisan Partners Reduced its Exact Sciences Corp. (EXAS) Position
Artisan Partners, a high value-added investment management firm, published its ‘Artisan Mid Cap Fund’ third quarter 2021 investor letter – a copy of which can be downloaded...
11 Best Genomic Stocks to Buy Now
In this article, we will take a look at the 11 best genomic stocks to buy now.
Should I Avoid EXACT Sciences Corporation (EXAS)?
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy...
Exact Sciences (EXAS), A Top Detractor in RiverPark’s Q2 Results
RiverPark Funds, an investment management firm, published its “RiverPark Large Growth Fund” second quarter 2021 investor letter – a copy of which can be downloaded here.
10 Reddit’s WallStreetBets Stocks That are Tumbling
In this article, we discuss the 10 Reddit's WallStreetBets stocks that are tumbling.
EXACT Sciences Corporation (EXAS): Are Hedge Funds Right About This Stock?
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
10 Best Biotech Stocks to Buy According to Cathie Wood
In this article we will take a look at the 10 best biotech stocks to buy according to Cathie Wood.
5 Best Biotech Stocks to Buy According to Cathie Wood
In this article we discuss the 5 best biotech stocks to buy according to Cathie Wood.
10 Best Stocks to Buy in 2021 According to Cathie Wood
In this article we will take a look at the 10 best stocks to buy in 2021 according to Cathie Wood.
Is EXACT Sciences (EXAS) Stock A Buy or Sell?
While the market driven by short-term sentiment influenced by the accommodative interest rate environment in the US, virus news and stimulus spending, many smart money investors...
Is It Too Late to Buy EXACT Sciences (EXAS) Stock?
RiverPark Advisors, LLC recently published its Q4 2020 RiverPark Large Growth Fund commentary – a copy of which can be downloaded here.
Is Exact Sciences Corp. (EXAS) A Smart Long-Term Buy?
Artisan Partners Limited Partnership, a high value-added investment management firm, published its ‘Artisan Mid Cap Fund’ fourth quarter 2020 investor letter – a copy of...
Is EXAS A Good Stock To Buy According To Hedge Funds?
The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers included in our extensive...
Is EXACT Sciences Corp (EXAS) a Smart Long-term Buy?
RiverPark Advisors, LLC recently published its Q3 2020 RiverPark Large Growth Fund commentary – a copy of which can be downloaded here.
Was The Smart Money Right About Crowding Into EXACT Sciences Corporation (EXAS)?
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns.
EXACT Sciences (EXAS) Has Fallen 28% in Last One Year, Underperforms Market
If you are looking for the best ideas for your portfolio you may want to consider some of RiverPark Advisors top stock picks.
Hedge Funds Never Been This Bullish On EXACT Sciences Corporation (EXAS)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Did Hedge Funds Make The Right Call On XACT Sciences Corporation (EXAS) ?
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Hedge Funds Cashing Out Of EXACT Sciences Corporation (EXAS)
In this article you are going to find out whether hedge funds think EXACT Sciences Corporation (NASDAQ:EXAS) is a good investment right now.
Should Investors Buy the Dip in EXACT Sciences (EXAS) Stock?
Artisan Mid Cap Fund recently released its Q1 2020 Investor Letter, a copy of which you can download below.
Hedge Funds Have Never Been This Bullish On EXACT Sciences Corporation (EXAS)
Coronavirus is probably the #1 concern in investors' minds right now. It should be.
